TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 277 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $396,496 | -1.5% | 25,630 | 0.0% | 0.04% | +18.8% |
| Q2 2023 | $402,647 | -4.7% | 25,630 | 0.0% | 0.03% | -15.8% |
| Q1 2023 | $422,382 | +5.6% | 25,630 | 0.0% | 0.04% | +2.7% |
| Q4 2022 | $399,828 | +20.4% | 25,630 | 0.0% | 0.04% | +8.8% |
| Q3 2022 | $332,000 | -7.8% | 25,630 | 0.0% | 0.03% | -19.0% |
| Q2 2022 | $360,000 | -1.9% | 25,630 | 0.0% | 0.04% | +31.2% |
| Q1 2022 | $367,000 | +5.2% | 25,630 | 0.0% | 0.03% | +28.0% |
| Q4 2021 | $349,000 | -16.9% | 25,630 | 0.0% | 0.02% | -10.7% |
| Q3 2021 | $420,000 | -2.6% | 25,630 | 0.0% | 0.03% | +7.7% |
| Q2 2021 | $431,000 | -91.2% | 25,630 | -90.9% | 0.03% | -96.5% |
| Q3 2019 | $4,871,000 | -33.6% | 283,200 | -31.7% | 0.74% | -27.8% |
| Q2 2019 | $7,338,000 | -12.8% | 414,627 | +0.4% | 1.02% | -6.9% |
| Q1 2019 | $8,416,000 | – | 413,136 | – | 1.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Glenview Capital Management | 16,104,222 | $294,063,000 | 4.98% |
| GMT CAPITAL CORP | 2,468,695 | $45,078,000 | 3.31% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,065,756 | $19,461,000 | 3.13% |
| Blackcrane Capital, LLC | 14,571 | $1,723,000 | 2.72% |
| BFAM Partners (Cayman) Ltd | 328,690 | $6,002,000 | 2.36% |
| Paulson & Co. | 4,727,415 | $86,323,000 | 1.98% |
| Mondrian Investment Partners LTD | 3,510,404 | $59,677,000 | 1.28% |
| Lumbard & Kellner, LLC | 135,550 | $2,264,000 | 0.80% |
| DAVIDSON INVESTMENT ADVISORS | 500,203 | $9,134,000 | 0.78% |
| TFG Asset Management GP Ltd | 589,390 | $10,762,000 | 0.77% |